BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 34481011)

  • 1. Strategies for the delivery of antidiabetic drugs via intranasal route.
    Dholakia J; Prabhakar B; Shende P
    Int J Pharm; 2021 Oct; 608():121068. PubMed ID: 34481011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy.
    Wong CYJ; Baldelli A; Hoyos CM; Tietz O; Ong HX; Traini D
    Drug Deliv Transl Res; 2024 Jul; 14(7):1776-1793. PubMed ID: 38441832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal delivery of high molecular weight drugs.
    Ozsoy Y; Gungor S; Cevher E
    Molecules; 2009 Sep; 14(9):3754-79. PubMed ID: 19783956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of nanoparticulate drug delivery systems by intranasal administration.
    Ali J; Ali M; Baboota S; Sahani JK; Ramassamy C; Dao L; Bhavna
    Curr Pharm Des; 2010 May; 16(14):1644-53. PubMed ID: 20210751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery.
    Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Gupta U; Kesharwani P; Ravichandiran V; Kumar P; Naidu VGM; Murty US; Ajazuddin ; Alexander A
    J Control Release; 2020 Nov; 327():235-265. PubMed ID: 32739524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
    Fortuna A; Alves G; Serralheiro A; Sousa J; Falcão A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):8-27. PubMed ID: 24681294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action.
    Henkin RI
    Nutrition; 2010 Jan; 26(1):33-9. PubMed ID: 20005465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review of advanced nasal delivery: Specially insulin and calcitonin.
    Luo D; Ni X; Yang H; Feng L; Chen Z; Bai L
    Eur J Pharm Sci; 2024 Jan; 192():106630. PubMed ID: 37949195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal route and drug delivery systems.
    Türker S; Onur E; Ozer Y
    Pharm World Sci; 2004 Jun; 26(3):137-42. PubMed ID: 15230360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends in drug delivery systems: intranasal drug delivery.
    Agarwal V; Mishra B
    Indian J Exp Biol; 1999 Jan; 37(1):6-16. PubMed ID: 10355359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose-Brain Drug Delivery.
    Taha E; Shetta A; Nour SA; Naguib MJ; Mamdouh W
    Mol Pharm; 2024 Mar; 21(3):999-1014. PubMed ID: 38329097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting nasal drug delivery and design strategies for intranasal drug delivery.
    Hu X; Yue X; Wu C; Zhang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):328-337. PubMed ID: 37476944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel strategies in the oral delivery of antidiabetic peptide drugs - Insulin, GLP 1 and its analogs.
    Ismail R; Csóka I
    Eur J Pharm Biopharm; 2017 Jun; 115():257-267. PubMed ID: 28336368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal route: an alternative approach for antiemetic drug delivery.
    Ozsoy Y; Güngör S
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1439-53. PubMed ID: 22004793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Nose to Brain Nano Delivery for Effective Management of Migraine.
    Tanna V; Sawarkar SP; Ravikumar P
    Curr Drug Deliv; 2023; 20(2):144-157. PubMed ID: 35366772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal delivery of insulin using bioadhesive chitosan gels.
    Varshosaz J; Sadrai H; Heidari A
    Drug Deliv; 2006; 13(1):31-8. PubMed ID: 16401591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery.
    Singh RM; Kumar A; Pathak K
    Expert Opin Drug Deliv; 2013 Jan; 10(1):115-30. PubMed ID: 23199072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal delivery of insulin by self-emulsified nanoemulsion system: In vitro and in vivo studies.
    Shah D; Guo Y; Ban I; Shao J
    Int J Pharm; 2022 Mar; 616():121565. PubMed ID: 35150847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Therapeutic Strategy in the Nasal Delivery of Insulin: Recent Advances and Future Directions.
    Chen J; Hu L; Yang G; Hu Q
    Curr Pharm Biotechnol; 2018; 19(5):400-415. PubMed ID: 29921203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.